BioInvent Expands U.S. Patent Protection for its F.I.R.S.T.™ Platform
The patent is expected to be issued once BioInvent has responded to the Notice.
- The patent is expected to be issued once BioInvent has responded to the Notice.
- This patent, once issued, strengthens the protection in the US.
- The now allowed application is a so called continuation application based on a US patent that was granted in 2013.
- A similar patent was granted some years earlier by the European patent office, and it is valid in 20 European countries.